Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Urofollitropin (75IU) Injection
Therapeutic Category
Gynecology and Fertility, ENDOCRINOLOGY and Hormonal range, Endocrinology
Dosage Form
Injection
Packaging Type
Vial
Packaging
75IU
Price
₹130/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Fertiedge FSH 75 Injection is a recombinant human follicle-stimulating hormone (FSH) used in assisted reproductive technologies to stimulate ovarian follicular development in women. It is indicated for women who are undergoing fertility treatments such as in vitro fertilization (IVF) or ovulation induction, to help promote the growth of mature eggs for fertilization. Urofollitropin, the active ingredient, mimics the natural FSH produced by the pituitary gland, helping to regulate and promote the development of eggs in the ovaries.
The injection is typically administered under the supervision of a healthcare provider, and the dosage is tailored based on the patient’s individual response. Fertiedge FSH 75 Injection is part of a larger fertility treatment regimen, often used in combination with other medications to optimize ovulation and improve the chances of conception. The use of this product is generally considered safe when prescribed by a fertility specialist, with appropriate monitoring for side effects.
Possible side effects include headache, ovarian hyperstimulation syndrome (OHSS), abdominal discomfort, nausea, and injection site reactions.
Indicated for ovulation induction and ovarian follicular development in fertility treatments.
Use only as prescribed by a healthcare professional. Do not self-administer without proper training.
Store in a refrigerator (2°C to 8°C). Do not freeze. Keep out of reach of children.
Composition : Menotrophin (75IU)
Composition : Human chorionic gonadotropin (hCG) (5000units)
Composition : Artesunate (120mg) Injection
Composition : Artesunate (60mg) Injection
Composition : Vancomycin (500mg) Injection
Composition : Vancomycin (1000mg) Injection
Composition : Amikacin (500mg)
Composition : Amikacin (250mg)
Composition : Amikacin (100mg)
Composition : Meropenem (500mg) Injection
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
Urofollitropin 75 IU Injection is a gonadotropin (FSH) hormone preparation used in fertility treatment and reproductive medicine. It is prescribed for ovulation induction in women with infertility, assisted reproductive techniques (ART), IVF cycles, and hormonal stimulation of ovaries. It is a key product in the gynecology, infertility, and reproductive endocrinology segment, mainly used in fertility clinics and IVF centers.
Medical distributors and wholesalers can benefit from growing demand due to rising infertility cases and increasing use of IVF/ART procedures in urban healthcare centers. Fertility medicines are specialist-driven, high-value, and protocol-based prescriptions, ensuring strong institutional sales and repeat cycle demand in IVF treatments.
Yes, Cafoli Lifecare offers PCD pharma pharma franchise opportunities in gynecology, fertility, and hormonal injectable segments with monopoly rights, quality manufacturing standards, and reliable supply support for distributors and medical agencies.
Wholesalers and institutional suppliers benefit from high-value prescriptions, IVF cycle-based repeat demand, and strong fertility clinic dependency, making it a specialized, high-margin, and growing pharmaceutical category when partnered with Cafoli Lifecare.
Medical distributors, stockists, and pharma professionals interested in fertility and gynecology injectables can contact Cafoli Lifecare to discuss product availability, pricing structure, and PCD pharma franchise opportunities in the reproductive health and IVF segment.